| Product NDC: | 0009-0555 |
| Proprietary Name: | Lincocin |
| Non Proprietary Name: | LINCOMYCIN HYDROCHLORIDE |
| Active Ingredient(s): | 300 mg/mL & nbsp; LINCOMYCIN HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-0555 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050317 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19641229 |
| Package NDC: | 0009-0555-01 |
| Package Description: | 2 mL in 1 VIAL (0009-0555-01) |
| NDC Code | 0009-0555-01 |
| Proprietary Name | Lincocin |
| Package Description | 2 mL in 1 VIAL (0009-0555-01) |
| Product NDC | 0009-0555 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LINCOMYCIN HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
| Start Marketing Date | 19641229 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | LINCOMYCIN HYDROCHLORIDE |
| Strength Number | 300 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes |